![]() ![]() Although treatable by liver transplantation, quality of life is unlikely to drop in all the patients after five years. Liver cirrhosis is a leading cause of mortality worldwide. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Baskar Subramani, Nichi-Asia Life Science Sdn Bhd, (786331-D) 57, Block F, Jalan Teknology 3/9 Bistari "De" Kota, Kota Damansara PJU 5, 47810 Petaling Jaya Selangor Darul Eshan, Malaysia, Tel: +603-6142-1920/21, Fax: +603-6142.Ĭitation: Gounder SS, Kodiappan R, Chan SC, Veerakumarasivam A, Subramani B (2017) Adult Stem Cell Therapy in Liver Cirrhosis Management: Current Practices and Future Perspectives. Sellamuthu Subbanna Gounder 1, Radha Kodiappan 2, Soon Choy Chan 3, Abhi Veerakumarasivam 4 and Baskar Subramani 1*ġNichi-Asia Life Science Sdn Bhd, Selangor, MalaysiaĢPerdana University Royal College of Surgeon Ireland, Perdana University, 43400 Serdang, Selangor Darul Ehsan, MalaysiaģPerdana University School of Foundation Studies (PUSFS), Perdana University, 43400 Serdang, Selangor Darul Ehsan, MalaysiaĤSunway Institute for Healthcare Development, Sunway University, Bandar Sunway, 47500 Subang Jaya, Selangor Darul Ehsan, Malaysiaĭr. REVIEW ARTICLE | VOLUME 4, ISSUE 2 | OPEN ACCESS DOI: 10.23937/2469-570X/1410049Īdult Stem Cell Therapy in Liver Cirrhosis Management: Current Practices and Future Perspectives ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |